Vireo Growth (VREOF) Current Taxes (2020 - 2025)
Vireo Growth (VREOF) posted Current Taxes of $2.9 million for Q3 2025, down 50.68% sequentially from $6.0 million in Q2 2025, and up 1427.05% YoY from $192716.0 in Q3 2024.
Vireo Growth (VREOF) Current Taxes (2020 - 2025) Analysis & Trends
Vireo Growth has reported Current Taxes for 6 years, with the latest figure at $2.9 million in Q3 2025.
- Quarterly Current Taxes rose 1427.05% year-over-year to $2.9 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2.9 million (up 1427.05% YoY) and the FY2024 annual result came in at $264518.0, up 21.03% from the prior year.
- Current Taxes fell to $2.9 million in Q3 2025 per VREOF's latest filing, from $6.0 million in the prior quarter.
- Over five years, Current Taxes peaked at $12.6 million in Q3 2023 and troughed at $179378.0 in Q2 2024.
- A 5-year average of $4.4 million and a median of $4.7 million in 2022 frame the typical range for Current Taxes.
- The sharpest annual moves came in 2024 and 2025: Current Taxes sank 98.47% in 2024, then jumped 3226.47% in 2025.
- Over 5 years, Current Taxes stood at $5.2 million in 2021, then gained by 18.66% to $6.2 million in 2022, then tumbled by 96.46% to $218563.0 in 2023, then climbed by 21.03% to $264518.0 in 2024, then soared by 1012.54% to $2.9 million in 2025.
- According to Business Quant data, Current Taxes over the past three periods registered $2.9 million, $6.0 million, and $199088.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -355.54 Mn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 138.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 739.89 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 46.00 Mn |
| 10 | Vireo Growth | 482.88 Mn | 340.58 Mn | 95.30 Mn | 12.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.94 Mn |
| Jun 30, 2025 | 5.97 Mn |
| Mar 31, 2025 | 199,088.00 |
| Dec 31, 2024 | 264,518.00 |
| Sep 30, 2024 | 192,716.00 |
| Jun 30, 2024 | 179,378.00 |
| Mar 31, 2024 | 346,450.00 |
| Dec 31, 2023 | 218,563.00 |
| Sep 30, 2023 | 12.63 Mn |
| Jun 30, 2023 | 8.50 Mn |
| Mar 31, 2023 | 7.97 Mn |
| Dec 31, 2022 | 6.17 Mn |
| Sep 30, 2022 | 6.42 Mn |
| Jun 30, 2022 | 4.65 Mn |
| Mar 31, 2022 | 6.60 Mn |
| Dec 31, 2021 | 5.20 Mn |
| Sep 30, 2021 | 3.00 Mn |
| Jun 30, 2021 | 2.73 Mn |
| Mar 31, 2021 | 8.99 Mn |
| Dec 31, 2020 | 7.23 Mn |